.alpha.- and .beta.-amino acid hydroxyethlamino sulfonyl urea derivatives useful as retroviral protease inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7232817
APP PUB NO 20060094789A1
SERIAL NO

11235524

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

.alpha.- and .beta.-amino acid hydroxyethylamino sulfonyl urea derivative compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
G. D. Searle & Co.CHICAGO, IL176
MONSANTO COMPANYST LOUIS, MO294

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
DeCrescenzo, Gary A St. Peters, MO 161 1298
Getman, Daniel P Chesterfield, MO 158 1014
Mueller, Richard A Glencoe, IL 223 2304
Sun, Eric T San Diego, CA 45 218
Talley, John J Chesterfield, MO 230 2295
Vazquez, Michael L Gurnee, IL 147 1364

Cited Art Landscape

Patent Info (Count) # Cites Year
 
Other [Check patent profile for assignment information] (1)
H725 Ureido amino and imino acids, compositions and methods for use 133 1987
 
MERCK & CO., INC. (2)
4668770 Renin inhibitory tripeptides 155 1984
4880938 Amino acid analogs 113 1986
 
MONSANTO COMPANY (1)
5578606 .alpha.- and .beta.-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors 11 1992
 
ABBOTT LABORATORIES (1)
4977277 Functionalized peptidyl aminodiols and -triols 4-amino-5-cyclohexyl-3-hydroxy-1,2-oxopentane and derivatives thereof 135 1989
 
SANKYO COMPANY, LIMITED (1)
4548926 Hypotensive peptides and their use 162 1984
 
MERCK & CO., LTD. (1)
4477441 Renin inhibitors containing a C-terminal disulfide cycle 148 1983
 
E. R. Squibb & Sons, Inc. (3)
4514391 Hydroxy substituted peptide compounds 143 1983
4616088 Amino acid ester and amide renin inhibitor 153 1984
4757050 Ureido renin inhibitors 136 1987
 
SCHERING CORPORATION (1)
4450164 Imidazo[1,2-A]pyridines and use 142 1982
 
FUJISAWA PHARMACEUTICAL CO., LTD. (1)
4963530 Renin inhibitor peptide compounds, a process for the preparation thereof and pharmaceutical composition comprising the same 139 1988
 
PFIZER INC. (2)
4668769 Oxa- and azahomocyclostatine polypeptides 143 1985
4599198 Intermediates in polypeptide synthesis 158 1985
 
G. D. Searle & Co. (4)
6022872 .alpha.- and .beta.-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors 14 1996
6211176 .alpha.- and .beta.-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors 9 1999
6403585 .alpha.-and .beta.-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors 2 2000
6683648 .alpha.- and .beta.-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors 2 2002
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

  • No Forward Cites to Display

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 19, 2018
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00